Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Stocks: Turn Up the Volume


Q: Some pharmas are out of favor -- what's your take on Amylin (AMLN )?

A: The chart on AMLN looks moderately constructive. It's in a basing process. If it can jump back above the $26 level, the technicals would turn much more bullish. Relative to other pharmaceutical stocks, this one looks pretty good.

Q: How will Martha Stew


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus